Raymond Prudo-Chlebosz insider trades

Open-market stock purchases and sales by Raymond Prudo-Chlebosz, Director at Akari Therapeutics plc, from SEC Form 4 filings since May 31, 2024.

Recent trades

DateStockTradeValue
Oct 5, 2026AKTX Akari Therapeutics plcBought (not open market)$25.6K
Aug 18, 2026AKTX Akari Therapeutics plcBought (not open market)$71.7K
Aug 18, 2026AKTX Akari Therapeutics plcBought (not open market)—
Aug 18, 2026AKTX Akari Therapeutics plcBought (not open market)—
Dec 16, 2025AKTX Akari Therapeutics plcBought$156K
Dec 16, 2025AKTX Akari Therapeutics plcBought$250K

Companies traded

  • AKTX Akari Therapeutics plc: 2 buys, last Oct 5, 2026

Get free alerts when Raymond Prudo-Chlebosz files a new trade →